You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

CLINICAL TRIALS PROFILE FOR RESTASIS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RESTASIS

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00348335 ↗	Efficacy of Topical Cyclosporin for Ocular Rosacea	Completed	Allergan	Phase 4	2006-06-01	The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
NCT00348335 ↗	Efficacy of Topical Cyclosporin for Ocular Rosacea	Completed	Ophthalmic Consultants of Long Island	Phase 4	2006-06-01	The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
NCT00349440 ↗	Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy	Completed	Innovative Medical	Phase 4	2006-09-01	The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photorefractive keratectomy (PRK).
NCT00399061 ↗	Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms	Completed	Innovative Medical	Phase 4	2006-11-01	The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RESTASIS

Condition Name

Chart
Table

Condition Name for RESTASIS
Intervention	Trials
Dry Eye Syndromes	13
Dry Eye	10
Dry Eye Syndrome	5
Dry Eye Disease	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RESTASIS
Intervention	Trials
Dry Eye Syndromes	37
Keratoconjunctivitis Sicca	33
Eye Diseases	13
Syndrome	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RESTASIS

Trials by Country

Map
Table

Trials by Country for RESTASIS
Location	Trials
United States	70
Korea, Republic of	7
Thailand	2
Singapore	2
India	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RESTASIS
Location	Trials
California	9
Massachusetts	6
Texas	5
North Carolina	5
New York	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RESTASIS

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RESTASIS
Clinical Trial Phase	Trials
Phase 4	16
Phase 3	11
Phase 2	11
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RESTASIS
Clinical Trial Phase	Trials
Completed	35
Recruiting	4
Terminated	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RESTASIS

Sponsor Name

Chart
Table

Sponsor Name for RESTASIS
Sponsor	Trials
Allergan	13
Innovative Medical	6
Huons Co., Ltd.	5
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RESTASIS
Sponsor	Trials
Industry	42
Other	27
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.